Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma

Simona Ruggieri, Roberto Tamma, Nicoletta Resta, Francesco Albano, Nicoletta Coccaro, Daria Loconte, Tiziana Annese, Mariella Errede, Giorgina Specchia, Rebecca Senetta, Paola Cassoni, Domenico Ribatti, Beatrice Nico

Research output: Contribution to journalArticlepeer-review


With the aim of elucidating the relationship between Stat3 expression and tumor vessels abnormalities in the PCNLs, in this study we evaluated Stat3 and pStat3 expression by Real-time PCR and by immunohistochemistry in biopsy sections from PCNSL patients. Correlations of the expression levels with the presence of aberrant vessels were analyzed by confocal laser microscopy analysis, using FVIII as endothelial cell marker, CD133 and nestin as cancer stem cell (CSC) marker, CD20 as tumor cell marker, and Stat3. In addition, we investigated Stat3 mutations in lymphoma cells to clarify the role of the constitutive expression of Stat3 and of its phosphorylated forms. Results showed that in PCNSL, putative endothelial cells lining the vessels are heterogeneous, expressing FVIII/pStat3/CD133 (presumably originally they are vascular progenitor cells), as well as FVIII/CD20/CD133 (presumably originally they are tumor cells). Finally, we detected a fraction of the FVIII+ endothelial cell that co-expressed Stat3 bearing a tetraploid karyotype, while no amplification signal for the Stat3 gene was detected.

Original languageEnglish
Pages (from-to)31254-31269
Number of pages16
Issue number19
Publication statusPublished - May 9 2017


  • Angiogenesis
  • Cancer stem cells
  • Endothelium
  • Lymphoma
  • Stat3

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma'. Together they form a unique fingerprint.

Cite this